MicroRNA-424 regulates cisplatin resistance of gastric cancer by targeting SMURF1 based on GEO database and primary validation in human gastric cancer tissues

PURPOSE: Cisplatin (DDP) based chemotherapy regimens are widely used in advanced gastric cancer (GC). Drug resistance often limited the clinical benefits of cisplatin regimen. The mechanisms of cisplatin resistance have not been fully revealed. Therefore, further exploration of the relevant molecula...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Li, Wu, Menglin, Lu, Yaoheng, Zhao, Zhicheng, Liu, Tong, Fu, Weihua, Li, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756437/
https://www.ncbi.nlm.nih.gov/pubmed/31571913
http://dx.doi.org/10.2147/OTT.S208275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756437/
https://www.ncbi.nlm.nih.gov/pubmed/31571913
http://dx.doi.org/10.2147/OTT.S208275

Ejemplares similares